Article

Prehistoric Molecular Code Offers New Insight on Cancer Cell Migration

Researchers find mechanism that enables cells to migrate in a specific tissue.

A study published in the online journal Nature Structural and Molecular Biology reported the discovery of an undescribed protein sequence critical to cell motility regulation.

"Cell motility is essential for all life,” said lead researcher and University of Turku professor, Johanna Ivaska. “In humans it plays a vital role from embryonic development to inflammation, immune responses and wound healing in adults. Furthermore, in cancer cell migration facilitates the metastatic dissemination."

The protein sequence in adhesion receptors are called integrins. These are a family of proteins that consist of alpha and beta subtypes, which function by attaching the cell cytoskeleton to the extracellular matrix and sensing if adhesion had occurred.

"Cell motility is essential for all life. In humans it plays a vital role from embryonic development to inflammation, immune responses and wound healing in adults. Furthermore, in cancer cell migration facilitates the metastatic dissemination," said University of Turku Academy Professor Johanna Ivaska.

Scientists have always known that human cells require adhesion receptors to be recycled in order to allow for cell motility, but they were unaware of the grounds for specific regulation in different environments in the body.

This molecular code predates dinosaurs and is a functional part of our bodies today. With this code, researchers are able to explain how cells can tweak their migration from different tissues on a molecular level.

"Our new observation demonstrate for the first time the mechanism which enables cells to specifically turnover their adhesions to migrate in a specific tissue,” Ivaska said. “The ancient mechanisms remains today vital for human health and plays a role in pathological situations like chronic inflammation, some autoimmune diseases and cancer.”

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards